ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Dingxin Recipe IV attenuates atherosclerosis by regulating lipid metabolism through LXR-α/SREBP1 pathway and modulating the gut microbiota in ApoE-/- mice fed with HFD

Zhang, Yaxin; Gu, Yuyan; Chen, Yihao; Huang, Zhiyong; Li, Mei; Jiang, Weihao; Chen, Jiahui; Rao, Wenting; Luo, Shangfei; Chen, Yuyao; Chen, Junqi; Li, Lijun; Jia, Yuhua*; Liu, Menghua*; Zhou, Fenghua*南方医科大学; 中山大学
Journal of Ethnopharmacology2021-2-10DOI: 10.1016/j.jep.2020.113436
48被引6阅读
引用收藏
分享

摘要

Ethnopharmacological relevance: Dingxin Recipe (DXR) is a traditional Chinese medicine formula that has been reported to be effective and safe treatment for cardiovascular diseases, such as arrhythmias, coronary heart disease. Dingxin Recipe IV (DXR IV) was further improved from the DXR according to the traditional use. However, the mechanism of DXR IV in atherosclerosis is unclear. @@@ Aim of the study: This study aimed to illustrate whether DXR IV improve atherosclerosis through modulating the lipid metabolism and gut microbiota in atherosclerosis mice. @@@ Materials and methods: 40 male ApoE-/mice were fed on HFD for 12 weeks and were then treated with DXR IV (1.8, 0.9, or 0.45 g/kg/d) for another 12 weeks. The decroation of DXR IV contains four traditional Chinese medicines: the dried rhizome of Coptis chinensis Franch. (15.09%), the root of Salvia miltiorrhiza Bunge (28.30%), the seed of Ziziphus jujuba Mill. (37.74%) and the fruiting body of Ganoderma lucidum (Leyss.ex Fr.) Karst. (18.87%). 8 male c57BL/6 mice fed a normal diet served as control group. The atherosclerotic plaque was quantified by oil-red O staining and masson trichrome staining. Mice feces were collected. The gut micobiota were detected by 16S rRNA gene sequencing and fecal metabolites were analyzed by 1H NMR spectroscopy. The effect of DXR IV on blood lipids (TG, TC, LDL-C, HDL-C) was investigated. The lipid metabolism related genes were determined by RT-qPCR and western blotting respectively. @@@ Results: DXR IV exerted the anti-atherosclerosis effect by inhibiting the excessive cholesterol deposition in aorta and regulating the level of TG, TC, LDL-C and HDL-C. The composition of gut microbiota was changed. Interestingly, the relative abundance of Muribaculaceae and Ruminococcaceae increased after DXR IV administration, whereas the abundance of Erysipelotrichaceae decreased, which have been beneficial to lipid metabolism. Nine potential metabolic biomarkers, including acetate, butyrate, propionate, alanine, succinate, valerate, xylose, choline, glutamate, were identified, which were related to fatty acid metabolism. Further, the pathway of fatty acid was detected by the RT-qPCR and western blotting. Compared with model group, the level of LXR-alpha and SREBP1 decreased significantly in DXR IV group while LXR-beta, SREBP2 showed no statistical significance. It indicated that DXR IV modulated lipid metabolism by LXR-alpha/SREBP1 but not LXR beta and SREBP2. @@@ Conclusions: DXR IV exhibits potential anti-atherosclerosis effect, which is closely related to lipid metabolism and the gut microbiota. This study may provide novel insights into the mechanism of DXR IV on atherosclerosis and a basis for promising clinical usage.

学科与关键词

关键词
AtherosclerosisGut microbiotaDingxin recipe IVLipid metabolismTraditional Chinese medicine
相关
加载中…
  • Dingxin recipe III ameliorates hyperlipidemia injury in SD rats by improving the gut barrier, particularly the SCFAs/GPR43 pathway
    Gu, Yu-yan; Cui, Xiao-bing; Jiang, Jing; Zhang, Ya-xin; Liu, Meng-hua; Cheng, Sai-bo; Li, Yu-ye; Liu, Lin -ling; Liao, Rong-xin; Zhao, Peng; Jin, Wen; Jia, Yu-hua*; Wang, Jing*; Zhou, Feng-hua*Journal of Ethnopharmacology, 2023, 312: 116483.
  • The Role of Ophiopogonin D in Atherosclerosis: Impact on Lipid Metabolism and Gut Microbiota
    Zhang, Ya-Xin; Qu, Shan-Shan; Zhang, Li-Hua; Gu, Yu-Yan; Chen, Yi-Hao; Huang, Zhi-Yong; Liu, Meng-Hua; Zou, Wei; Jiang, Jing; Chen, Jun-Qi*; Wang, Yu-Jue*; Zhou, Feng-Hua*AMERICAN JOURNAL OF CHINESE MEDICINE, 2021, 49(06): 1449-1471.被引 10
  • Ferulic Acid Ameliorates Atherosclerotic Injury by Modulating Gut Microbiota and Lipid Metabolism
    Gu, Yuyan; Zhang, Yaxin; Li, Mei; Huang, Zhiyong; Jiang, Jing; Chen, Yihao; Chen, Junqi; Jia, Yuhua; Zhang, Lihua*; Zhou, Fenghua*Frontiers in Pharmacology, 2021, 12: 621339.被引 37
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Ethnopharmacology
发表日期
2021-02-10
卷期
第 266 卷
页码
113436
DOI
10.1016/j.jep.2020.113436
语言
ENGLISH
期刊收录
NSL
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Sciences Foundation of China [81774213, 81973802]; Project of Traditional Chinese Medicine Bureau of Guangdong Province [20201233]

作者

  • Z

    Zhang, Yaxin (第一作者)

    southern med univ

  • G

    Gu, Yuyan

    southern med univ

查看全部 15 位作者收起作者
  • C

    Chen, Yihao

    southern med univ

  • H

    Huang, Zhiyong

    southern med univ

  • L

    Li, Mei

    sun yat sen univ

  • J

    Jiang, Weihao

    southern med univ

  • C

    Chen, Jiahui

    southern med univ

  • R

    Rao, Wenting

    southern med univ

  • L

    Luo, Shangfei

    southern med univ

  • C

    Chen, Yuyao

    southern med univ

  • C

    Chen, Junqi

    southern med univ

  • L

    Li, Lijun

  • J

    Jia, Yuhua (通讯)

    southern med univ

  • L

    Liu, Menghua (通讯)

    southern med univ

  • Z

    Zhou, Fenghua (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417